A total of 31 patients underwent an evaluation before and eight after 2018, respectively, and one patient was specifically addressed to test the GCM2 p.Tyr394Ser variant as she was of Ashkenazi origin with FIHP without any syndromic feature (see Figure 1 describing the chart of patients’ selection). This evidence concerns the gene GCM2 and familial isolated hyperparathyroidism.